EP3924054
3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.2.2020EP published:
2.4.2025EP application number:
20708198.5
EPO information:
European Patent Register
Max expiry date:
12.2.2040
Title in English:
3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
13.2.2020EP application
2.4.2025EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BECKWITH, Rohan Eric JohnAddress:
Cambridge, Massachusetts 02139, US
Name:
BONAZZI, SimoneAddress:
Cambridge, Massachusetts 02139, US
Name:
CERNIJENKO, ArtiomAddress:
Cambridge, Massachusetts 02139, US
Name:
VISSER, Michael ScottAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201962806140 PDate:
15.2.2019Country:
US
Classification
Categories:
A61P 35/00, C07D 401/04, C07D 401/14, A61K 31/454